definiens: . The Liver Term means the period beginning on the New CLA Effective Date and ending on the later of ( a ) [ * * * ] ( [ * * * ] ) years from the date of initiation of work under the Resea rch Plan for Liver, and ( b ) the date on which 4DMT delivers [ * * * ] ( [ * * * ] ) ( i.e., when it has delivered [ * * * ] ) New L iver Variants to [COMPANY] with the Vector Characterizatio n Data with respect to each of such [ * * * ] ( [ * * * ] ) N ew Liver Variants that the Research Plan for Liver requires 4DMT to provide . It is understood that the Selectio n Processes giving rise to such New Liver Variants shall be the Selection Processes directed at identifying liver -targeted variants as defined and called for in the Research Plan, or, if such Selection Processes do not yield [ * * * ] ( [ * * * ] ) New Liver Variants meeting the Delivery Success Cri teria ( that can then proceed into the studies that generate Vector Characterization Data in accordance with the Research Plan for Liver ), then Selection Processes for liver - targeted AAV Capsid Variants that 4DMT conducts in addition or as follow - ups to ( but in each case not in replacement or in lieu of ) such liver - directed Sele ction Processes called for in the Research Plan, an d in any event meeting the requirements of Section 3.1 . If 4 DMT conducts such in - addition - to and/or follow - up l iver -directed Selection Processes, then the Vector Chara cterization Data that 4DMT would have to report to [COMPANY] in order for the applicable New Liver Variants to c ount as one of the [ * * * ] ( [ * * * ] ) New Liver Variants of clause ( b ) of the first sentence of this definition, shall be equivalent to the Vector Characterization Data that 4DMT is required to report to [COMPANY] under the Research Pl an with respect to the New Liver Variants that it d elivers thereunder . [COMPANY] ’s information and input rights as to any such additional Selection Processes that 4DMT may choose to conduct are as provided for in Section 3 . 1